A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy

NCT00261677 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Hodgkin Disease
Leukemia
Lymphoma, Non-hodgkin

Interventions

DRUG: epoetin alfa

Sponsor

Ortho Biotech Products, L.P.